Efthymios P Tsounis
Overview
Explore the profile of Efthymios P Tsounis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
80
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kafentzi T, Tsounis E, Tourkochristou E, Avramopoulou E, Aggeletopoulou I, Geramoutsos G, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076474
Vitamin D receptor (VDR) single-nucleotide polymorphisms (SNPs) modulate vitamin D/VDR signaling, a key pathway in inflammatory bowel disease (IBD) pathogenesis. This study investigates how ApaI, BsmI, TaqI, and FokI SNPs...
2.
Kalafateli M, Tourkochristou E, Tsounis E, Aggeletopoulou I, Triantos C
Inflamm Bowel Dis
. 2024 Dec;
31(2):579-592.
PMID: 39680685
Strictures in inflammatory bowel disease, especially Crohn's disease (CD), are characterized by increased intestinal wall thickness, which, according to recent accumulating data, is mainly attributed to the expansion of the...
3.
Pastras P, Zazas E, Kalafateli M, Aggeletopoulou I, Tsounis E, Kanaloupitis S, et al.
Cancers (Basel)
. 2024 Jul;
16(14).
PMID: 39061161
Chronic hepatitis B (CHB) infection constitutes a leading cause of hepatocellular carcinoma (HCC) development. The identification of HCC risk factors and the development of prognostic risk scores are essential for...
4.
Aggeletopoulou I, Tsounis E, Triantos C
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38732118
Metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasingly prevalent condition characterized by abnormal fat accumulation in the liver, often associated with metabolic disorders. Emerging evidence suggests a potential link...
5.
Assimakopoulos S, Bhagani S, Aggeletopoulou I, Tsounis E, Tsochatzis E
Infection
. 2024 Feb;
52(3):723-736.
PMID: 38324146
Purpose: Gut barrier dysfunction is a pivotal pathophysiological alteration in cirrhosis and end-stage liver disease, which is further aggravated during and after the operational procedures for liver transplantation (LT). In...
6.
Aggeletopoulou I, Kalafateli M, Tsounis E, Triantos C
Front Med (Lausanne)
. 2024 Feb;
11:1307394.
PMID: 38323035
Interleukin 1β (IL-1β) is a significant mediator of inflammation and tissue damage in IBD. The balance between IL-1β and its endogenous inhibitor-IL-1Ra-, plays a critical role in both initiation and...
7.
Kounis N, Gogos C, de Gregorio C, Hung M, Kounis S, Tsounis E, et al.
Balkan Med J
. 2024 Jan;
41(1):7-22.
PMID: 38173173
Coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory coronavirus-2 (SARS-CoV-2). Several explanations for the development of cardiovascular complications during and after acute COVID-19 infection have been...
8.
Aggeletopoulou I, Tsounis E, Kalafateli M, Michailidou M, Tsami M, Zisimopoulos K, et al.
Medicina (Kaunas)
. 2023 Dec;
59(12).
PMID: 38138215
Specificity and reliability issues of the current cortisol assessment methods lead to limitations on the accurate assessment of relative adrenal insufficiency. Although free cortisol provides a more accurate evaluation of...
9.
Aggeletopoulou I, Kalafateli M, Tsounis E, Triantos C
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37629043
Nonalcoholic fatty liver disease (NAFLD), the most prominent cause of chronic liver disease worldwide, is a rapidly growing epidemic. It consists of a wide range of liver diseases, from steatosis...
10.
Aggeletopoulou I, Tsounis E, Mouzaki A, Triantos C
J Pers Med
. 2023 Jul;
13(7).
PMID: 37511642
During the course of Crohn's disease, the response of mesenteric adipose tissue to the production of inflammatory mediators and bacterial invasion through the intestinal mucosa results in the formation of...